Attached files
| file | filename |
|---|---|
| 8-K/A - FROM 8-K/A - ALEXION PHARMACEUTICALS, INC. | a8-kaenobiaacquisition.htm |
| EX-99.3 - UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - ALEXION PHARMACEUTICALS, INC. | alxn993proformaexhibit.htm |
| EX-99.2 - AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF ENOBIA - ALEXION PHARMACEUTICALS, INC. | alxn992enobiafinancialstat.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-127471, 333-123828, 333-91265, 333-29617, 333-41397, 333-47645, 333-89343, 333-36738, 333-52886 and 333-59702) and Form S-8 (No. 333-146319, 333-139600, 333-123212, 333-119749, 333-24863, 333-52856, 333-69478, 333-71879, 333-71985, 333-106854 and 333-153612) of Alexion Pharmaceuticals, Inc. of our report dated April 12, 2012 relating to the financial statements of Enobia Pharma Corp. which appears in the Current Report on Form 8-K of Alexion Pharmaceuticals, Inc. dated April 16, 2012.
/s/ PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP
Montréal, Quebec
April 16, 2012